Studying a new way to reduce risks during early stomach cancer surgery
Part of Cancer, Digestive system clinical trials.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 75 years old.
- You are scheduled to have an ESD procedure for early stomach cancer that is eligible under standard guidelines.
- You have not had any prior treatment (like surgery or chemotherapy) on your stomach.
- Your recent blood tests show a platelet count above 10×10^9/L and hemoglobin above 8.0 g/L.
- You have stopped taking any blood-thinning medications for the recommended time before the procedure.
- You are able to provide written consent to participate.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests a new way to perform ESD, a minimally invasive procedure to remove early-stage cancers or polyps from the digestive tract. The goal is to see if this new method is safer and more effective than the standard approach.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
This trial tests two medications, esomeprazole and sucralfate, to see if they help heal stomach ulcers after an endoscopic procedure (ESD) for early stomach cancer or pre-cancerous growths. It may help you if you need this procedure and have a larger ulcer afterwards.
This trial compares two ways to treat early stomach cancer: removing it through an endoscope versus doing an operation. It’s meant for a specific stomach-cancer type (undifferentiated) that has not spread, to see which approach may be better.
This trial tests whether removing nearby lymph nodes is enough, or if additional stomach-sparing surgery is needed, after a previous endoscopic procedure did not completely remove early stomach cancer. The goal is to see which approach is better for preventing cancer from spreading.
This trial studies a combined surgical approach using a camera through small incisions (laparoscopy) and a flexible tube through the mouth (endoscopy) to treat early-stage stomach cancer. It aims to see if this approach can safely remove the cancer while sparing nearby lymph nodes.
Hear when a new Early Gastric Cancer or Gastric Adenoma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.